30
Participants
Start Date
April 30, 2009
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2014
human myeloid progenitor cells
Single intravenous injection/infusion
Alfred I. duPont Hospital for Children, Wilmington
Children's National Medical Center, Washington D.C.
Nationwide Children's Hospital, Columbus
Cleveland Clinic, Taussig Cancer Institute, Cleveland
Medical College of Wisconsin, Milwaukee
University of Minnesota: Masonic Cancer Center, BMT Clinic, and Fairview Medical Center, Minneapolis
Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood
Children's Hospital of Orange County, Orange
Lead Sponsor
Department of Health and Human Services
FED
Cellerant Therapeutics
INDUSTRY